Immunovant, Inc.

IMVT

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001764013

SEC filings (opens in a new tab)

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding Immunovant, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of IMVT: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	169	2	186	+19
Shares	96.2M	699.5K	95.2M	−358.9K (−0.4%)
Value	$1.54B	$11.2M	$1.53B	+$5.65M (+0.4%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Immunovant, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to IMVT in Q3 2025
Institution	Shares	Value	% of portfolio
Marshall Wace, LLP	419,680	$6.77M	0.01%
Superstring Capital Management LP	341,348	$5.50M	5.42%
Jane Street Group, LLC	337,666	$5.44M	0.01%
Affinity Asset Advisors, LLC	300,000	$4.84M	0.45%
Assenagon Asset Management S.A.	205,219	$3.31M	0.00%
Exome Asset Management LLC	158,622	$2.56M	1.69%
Schonfeld Strategic Advisors LLC	115,750	$1.87M	0.01%
Tudor Investment Corp Et Al	90,766	$1.46M	0.01%
Silverarc Capital Management, LLC	50,000	$806.0K	0.12%
Prelude Capital Management, LLC	41,683	$671.9K	0.05%
Voleon Capital Management LP	39,035	$629.2K	0.02%
Algert Global LLC	34,900	$562.6K	0.01%
Voloridge Investment Management, LLC	31,950	$515.0K	0.00%
Nomura Holdings Inc	30,000	$483.6K	0.00%
Point72 (DIFC) Ltd	27,698	$446.5K	0.03%
Gsa Capital Partners LLP	27,148	$438.0K	0.04%
Aigen Investment Management, LP	19,134	$308.4K	0.05%
Dymon Asia Capital (Singapore) Pte. Ltd.	17,905	$288.6K	0.12%
Altfest L J & Co Inc	17,726	$285.7K	0.03%
Two Sigma Securities, LLC	17,281	$278.6K	0.04%
Graham Capital Management, L.P.	15,119	$243.7K	0.01%
Point72 Asia (Singapore) Pte. Ltd.	15,076	$243.0K	0.04%
Abc Arbitrage SA	14,639	$236.0K	0.02%
Bayesian Capital Management, LP	12,976	$209.2K	0.04%
Quantinno Capital Management LP	11,488	$185.2K	0.00%
Group One Trading, L.P.	9,041	$145.7K	0.00%
Aster Capital Management (DIFC) Ltd	2,058	$33.2K	0.02%
SRS Capital Advisors, Inc.	158	$2.55K	0.00%
Halbert Hargrove Global Advisors, LLC	83	$1.34K	0.00%
Quadrant Capital Group LLC	80	$1.29K	0.00%
Johnson Financial Group, Inc.	75	$1.21K	0.00%
Advisory Services Network, LLC	9	$145	0.00%
Avion Wealth	29	$0	0.00%
Cloud Capital Management, LLC	1	$0	0.00%

Sold out (15)

Institutions that held Immunovant, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of IMVT in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
ExodusPoint Capital Management, LP	241,694	$3.87M
Renaissance Technologies LLC	241,400	$3.86M
Aquatic Capital Management LLC	136,522	$2.18M
Squarepoint Ops LLC	84,919	$1.36M
Tejara Capital Ltd	84,394	$1.35M
Victory Capital Management Inc	31,507	$504.1K
Jain Global LLC	26,636	$426.2K
Ameriprise Financial Inc	23,553	$376.8K
Oxford Asset Management LLP	11,717	$187.5K
Skopos Labs, Inc.	6,720	$107.5K
Raymond James Financial Inc	300	$4.80K
Evolution Wealth Management Inc.	200	$3.20K
Bare Financial Services, Inc	31	$496
Caitong International Asset Management Co., Ltd	5	$80
Twin Peaks Wealth Advisors, LLC	3	$46

Not filed for Q3 2025 yet (2)

Institutions that held Immunovant, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMVT in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Norges Bank	687,662	$11.0M
E Fund Management Co., Ltd.	11,854	$189.7K